Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.83

€2.83

-7.520%
-0.23
-7.520%
-
 
10:32 / Tradegate WKN: A3DSV0 / Name: Cantourage Group / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Cantourage Group SE Stock

Cantourage Group SE took a tumble today and lost -€0.230 (-7.520%).
Our community identified positive and negative aspects for Cantourage Group SE stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Cantourage Group SE stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Cantourage Group SE in the next few years

Pros
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

News

EQS-News: Cantourage strengthens market presence in Poland with flower variety “Gelato 33”: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=25bb932e02e87fbbc253669ddb85c774
EQS-News: Cantourage strengthens market presence in Poland with flower variety “Gelato 33”
EQS-News: Cantourage strengthens market presence in Poland with flower variety “Gelato 33”
EQS-News: Q3 2025: Cantourage delivers strong operating performance in a challenging regulatory market environment
EQS-News: Q3 2025: Cantourage delivers strong operating performance in a challenging regulatory market environment
EQS-News: Q3 2025: Cantourage delivers strong operating performance in a challenging regulatory market environment
EQS-News: Cabinet decision on the Medical Cannabis Act meets broad criticism / Cantourage expects changes and prepares to expand its “Telecan” platform
EQS-News: Cabinet decision on the Medical Cannabis Act meets broad criticism / Cantourage expects changes and prepares to expand its “Telecan” platform
EQS-News: Cabinet decision on the Medical Cannabis Act meets broad criticism / Cantourage expects changes and prepares to expand its “Telecan” platform